- Issuer ticker
-
ESPR
- Reported as of
-
17 Mar 2023
- Net transaction value
-
-$937
- SEC form
-
4
- Accepted by SEC
-
20 Mar 2023, 16:16:20 UTC
Filing notes and source
Key filing fact
Eric Warren filed Form 4 for Esperion Therapeutics, Inc. (ESPR) on 20 Mar 2023.
Key facts
- This page summarizes Eric Warren's Form 4 filing for Esperion Therapeutics, Inc. (ESPR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Mar 2023, 16:16.
Change
- Previous filing in this sequence was filed on 15 Mar 2023.
- Current net transaction value: -$937.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ESPR
transaction
Common Stock
Sale
- Transaction value
- -$937
- Shares
- -526
- Change %
- -0.74%
- Price
-
$1.78
- Shares after
- 70,346
- Date
- 17 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote